Breaking News

Ahlstrom, a global leader in fiber-based specialty materials, and Hamilton AG are collaborating to drive the next generation of laboratory automation for Dried Blood Spot (DBS) sample processing. This collaboration combines Ahlstrom’s proven specimen collection solutions with the Hamilton easyPunch STAR platform. Together, the companies aim to elevate DBS cards as a practical, high-performance alternative to traditional liquid blood sampling—while delivering higher levels of automation, beginning with punching, and ensuring complete sample traceability from collection through final processing. Fully automated DBS workflows hold particular promise across key application areas, including nutrigenomics, newborn screening, veterinary diagnostics, and agrigenomics. Ahlstrom and Hamilton are committed to supporting these fields by developing seamless end-to-end automated solutions enabling fully unattended workflows capable of processing hundreds of DBS cards without operator intervention. Leveraging decades of expertise in DBS card manufacturing, Ahlstrom provides automation-optimized card formats while upholding its gold-standard tissue paper specifications. Following the acquisition of EBF, Ahlstrom is also the manufacturer of 903™ cards, the reference card for DBS applications. The acquisition has further strengthened Ahlstrom’s capabilities in specimen collection, card manufacturing, advanced printing, sequential numbering and custom packaging. Through this collaboration, Ahlstrom and Hamilton are setting a new standard for efficiency, reliability, and scalability in DBS sample processing—helping laboratories unlock greater throughput and consistency across critical testing applications. ”For our customers, the value of this collaboration is in connecting high-quality specimen collection with the next steps in the laboratory workflow. By working with Hamilton, we can help laboratories move toward more efficient and scalable DBS processing while maintaining the consistency and reliability they require,” said Tamara Quatrano, Vice President, Lab & Lab Science, Ahlstrom. “Combining Hamilton’s automation expertise with Ahlstrom’s DBS specimen collection solutions gives laboratories a practical path to reduce manual handling and process larger sample volumes with greater consistency and traceability. Together, we are exploring how automation can create value across a range of DBS applications,” said Roberto Fantozzi, Director Commercial Excellence, Hamilton AG. For further information, please contact: Annemiek Voorzee VP, Communications and Marketing annemiek.voorzee@ahlstrom.com Ahlstrom in brief Ahlstrom is a global leader in combining fibers into sustainable specialty materials. Our purpose is to Purify and Protect, with Every Fiber, for a Sustainable World. Our vision is to be the leading Sustainable Specialty Materials Company for all our stakeholders. Our three Core divisions, Filtration & Life Sciences, Food & Consumer Packaging, and Protective Materials, address global trends with safe and sustainable solutions. Our net sales in 2025 amounted to EUR 2.9 billion and we employ some 7,000 people. Read more www.ahlstrom.com. Hamilton in brief For more than 75 years, Hamilton Company has been a global life sciences leader in the design and manufacturing of precision measurement devices, automated liquid handling platforms, and sample management solutions. Headquartered in Reno, Nevada, with key manufacturing and R&D affiliates in Bonaduz, Switzerland, Franklin, Massachusetts, and Timisoara, Romania, Hamilton serves the scientific community through a robust network of sales and support offices worldwide. Hamilton’s expertise spans across liquid handling, process analytics, robotics, and automated storage, providing the foundational tools necessary for groundbreaking scientific research and clinical discovery. By combining the best-quality materials with skilled workmanship and a lifelong commitment to ISO 9001-certified precision, Hamilton ensures the highest level of performance and reliability. Hamilton remains dedicated to driving innovation and satisfying the evolving needs of laboratories across the globe, maintaining a steadfast focus on quality and customer success.

Latest Blogs

Before the US tariff policy changes enacted by the White House in April 2025, investors saw dividends as a stable source of income. In December 2024, according to the Wall Street Journal (WSJ), analysts forecast that dividend paying companies would be a stable investment because of uncertain sentiment around the US economy and stock market, […]

A new report from SDi, IBO’s publisher, reveals that demand for automated systems is impacting sales of sample preparation techniques. For certain extraction techniques, the growth of automated systems is outpacing the growth rates for manual equipment approaches. The SDi report, “Sample Preparation: NA Prep, Extraction Techniques, and Preparative Chromatography,” covers these three overarching categories […]

In 2025, the analytical and life science instrumentation industry weathered challenges such as funding constraints in the early-stage biotech and US academic and government sectors, as well as changes in tariff policies. Nonetheless, Strategic Directions International (SDi) predicts in its 2026 “Global Assessment Report” that the industry will overcome these obstacles by meeting demand in […]

Overview One of the latest major developments in the quest for greater use of new approach methodologies (NAMs), which are broadly defined as alternatives to animal testing for studying environmental and human health hazards, is the EU’s publication of its “Roadmap Towards Phasing Out Animal Testing for Chemical Safety Assessments.” Adopted by the European Commission […]

MOBILion Systems set out in 2015 to disrupt the LC-MS market. The company’s Structures for Lossless Ion Manipulation (SLIM)technology utilizes a printed circuit board and electrical fields to move ions along what the company describes as a “serpentine path,” replacing the shorter straight ion flight path found in other high-resolution IMS systems. Because the ions […]

Access IBO on Knowledge Center

Table of Contents

October 2, 2026 (Volume 35, Issue 12)

For more information, click here.

Articles

The 2026 IBO Design Awards

AI and Drug Development Will Shape Medtech s Future

Executive Briefing

Company hit with sales injunction, more speculation about possible M&A deal, and more headlines

Financial

IBO Lab Instrument and Product Stock Index Performs Exceptionally in September

Market Profile

Field-Flow Fractionation

Industry Watch

Clinical

Government and Academia

Energy

Region Watch

China

EU

China

News

Broad-Based Companies

MS & LC-MS and GC-MS

Life Science Instruments

Gene-Based Analysis

Protein-Based Analysis

Materials Characterization

Bottom Line

Companies’ latest financial results

Science and Medicine Group. © 2019 - Privacy Policy - All rights reserved.